Unconfigured Ad
Collapse
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
55,231 views
0 reactions
|
Last Post
by plant_hunt
11-06-2019, 05:43 AM
|
||
|
Started by vlspeed, 01-06-2013, 03:33 PM
|
0 responses
774 views
0 reactions
|
Last Post
by vlspeed
01-06-2013, 03:33 PM
|
||
|
Started by rspitale, 01-05-2013, 04:51 PM
|
0 responses
1,465 views
0 reactions
|
Last Post
by rspitale
01-05-2013, 04:51 PM
|
||
|
Started by adumitri, 01-03-2013, 02:40 PM
|
0 responses
1,453 views
0 reactions
|
Last Post
by adumitri
01-03-2013, 02:40 PM
|
||
|
Started by rpkngs, 01-03-2013, 12:55 AM
|
0 responses
1,080 views
0 reactions
|
Last Post
by rpkngs
01-03-2013, 12:55 AM
|
||
|
Started by jjmmii, 01-02-2013, 07:14 PM
|
0 responses
786 views
0 reactions
|
Last Post
by jjmmii
01-02-2013, 07:14 PM
|
||
|
Started by Nepher, 01-02-2013, 02:27 AM
|
0 responses
796 views
0 reactions
|
Last Post
by Nepher
01-02-2013, 02:27 AM
|
||
|
Started by spps, 12-31-2012, 10:58 PM
|
0 responses
765 views
0 reactions
|
Last Post
by spps
12-31-2012, 10:58 PM
|
||
|
Started by xyhuang, 12-29-2012, 03:00 AM
|
2 responses
946 views
0 reactions
|
Last Post
by xyhuang
12-30-2012, 03:50 PM
|
||
|
Started by cganote, 12-28-2012, 08:35 AM
|
0 responses
787 views
0 reactions
|
Last Post
by cganote
12-28-2012, 08:35 AM
|
||
|
Started by mohanviro, 12-22-2012, 01:24 AM
|
0 responses
1,094 views
0 reactions
|
Last Post
by mohanviro
12-22-2012, 01:24 AM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
09-01-2026, 05:41 AM -
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 10:22 AM
|
0 responses
5 views
0 reactions
|
Last Post
by SEQadmin2
Today, 10:22 AM
|
||
|
Started by SEQadmin2, Yesterday, 12:32 PM
|
0 responses
5 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 12:32 PM
|
||
|
Started by SEQadmin2, 08-24-2026, 10:32 AM
|
0 responses
48 views
0 reactions
|
Last Post
by SEQadmin2
08-24-2026, 10:32 AM
|